Andreas Halvorsen's position in BridgeBio Pharma is currently worth $768 Million. That's 2.50% of their equity portfolio (13th largest holding). The investor owns 10.49% of the outstanding BridgeBio Pharma stock. Andreas Halvorsen started to build up the position in BridgeBio Pharma in Q2 2019. Since then they sold 4.57 Million shares. The stake costed the investor $608 Million, netting the investor a gain of 26% so far.